Sun Sentinel |
FAU to host potentially groundbreaking drug trial for Alzheimer's-like disease
Sun Sentinel The double-blind trial will examine the effects of RVT-101, which stimulates the release of acetylcholine in the brain, on a total of 240 patients diagnosed with dementia with Lewy bodies, said Axovant officials. Results are expected in 2017, with the … Dementia vs Alzheimer's Disease "Being involved in research makes me feel valued," says York woman with Alzheimer's Sheffield MP backs new Alzheimer's Society campaign |